Skip to main navigation

Live - Top Menu

  • Clinical Trials
  • Investors & Media
  • Careers
  • Contact Us
Menu
Close

Main navigation

  • Our Focus
  • Our Research
  • Our Medicine
  • Our Story
Home > Investors & Media > Financial Information > SEC Filings
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

SEC Filings

SEC Filings

Filing date Form Description View
Feb 11, 2021 SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML
0000093751-21-000294.pdf
0000093751-21-000294.rtf
Feb 10, 2021 SC 13G/A

An amendment to the SC 13G filing

View HTML
0001104659-21-018366.pdf
0001104659-21-018366.rtf
Feb 10, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-21-020007.pdf
0001104659-21-020007.rtf
0001104659-21-020007.xls
Feb 08, 2021 SC 13G/A

An amendment to the SC 13G filing

View HTML
0000315066-21-001075.pdf
0000315066-21-001075.rtf
Feb 02, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-21-011073.pdf
0001104659-21-011073.rtf
0001104659-21-011073.xls
Feb 01, 2021 3

Initial filing by director officer or owner of more than ten percent.

View HTML
0001104659-21-010363.pdf
0001104659-21-010363.rtf
0001104659-21-010363.xls
Feb 01, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-21-010364.pdf
0001104659-21-010364.rtf
0001104659-21-010364.xls
Jan 29, 2021 SC 13G/A

An amendment to the SC 13G filing

View HTML
0000834237-21-003882.pdf
0000834237-21-003882.rtf
Jan 26, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-21-007782.pdf
0001104659-21-007782.rtf
0001104659-21-007782.xls
Jan 26, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-21-007779.pdf
0001104659-21-007779.rtf
0001104659-21-007779.xls

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

Live - Footer Menu

  • Privacy Policy
  • Privacy Shield Policy
  • Corporate Compliance
  • Terms of Use
  • Contact Us
  • Cookie Preferences
10 Hudson Yards, 37th Floor|New York, NY 10001|T: 844-782-ICPT
© 2020 Intercept Pharmaceuticals, Inc.